H&R GmbH & Co. KGaA Net Assets
H&R GmbH & Co. KGaA net assets. Based on the latest financial reports, H&R GmbH & Co. KGaA (2HRA) has net assets worth €452.10 Million EUR (≈ $528.55 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€983.64 Million ≈ $1.15 Billion USD) and total liabilities (€531.54 Million ≈ $621.43 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See H&R GmbH & Co. KGaA (2HRA) balance sheet quality index to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €452.10 Million |
| % of Total Assets | 45.96% |
| Annual Growth Rate | 9.12% |
| 5-Year Change | 35.08% |
| 10-Year Change | 63.2% |
| Growth Volatility | 17.36 |
Net Assets of H&R GmbH & Co. KGaA (2002–2024)
Net assets of H&R GmbH & Co. KGaA from 2002 to 2024. This chart illustrates how H&R GmbH & Co. KGaA's net assets have evolved over time, based on quarterly financial data. Also explore H&R GmbH & Co. KGaA (2HRA) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Net Assets for H&R GmbH & Co. KGaA (2002–2024)
The table below shows the annual net assets of H&R GmbH & Co. KGaA from 2002 to 2024. For live market cap and overall valuation, see market cap of H&R GmbH & Co. KGaA.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €468.58 Million ≈ $547.83 Million |
+2.40% |
| 2023-12-31 | €457.62 Million ≈ $535.00 Million |
-2.88% |
| 2022-12-31 | €471.16 Million ≈ $550.84 Million |
+15.35% |
| 2021-12-31 | €408.48 Million ≈ $477.55 Million |
+17.76% |
| 2020-12-31 | €346.88 Million ≈ $405.54 Million |
-4.56% |
| 2019-12-31 | €363.45 Million ≈ $424.91 Million |
+1.70% |
| 2018-12-31 | €357.37 Million ≈ $417.80 Million |
+4.27% |
| 2017-12-31 | €342.74 Million ≈ $400.70 Million |
+7.99% |
| 2016-12-31 | €317.40 Million ≈ $371.07 Million |
+10.54% |
| 2015-12-31 | €287.13 Million ≈ $335.68 Million |
+15.36% |
| 2014-12-31 | €248.90 Million ≈ $290.99 Million |
+31.58% |
| 2013-12-31 | €189.16 Million ≈ $221.15 Million |
-14.95% |
| 2012-12-31 | €222.42 Million ≈ $260.03 Million |
-7.76% |
| 2011-12-31 | €241.14 Million ≈ $281.92 Million |
+6.49% |
| 2010-12-31 | €226.44 Million ≈ $264.73 Million |
+24.64% |
| 2009-12-31 | €181.68 Million ≈ $212.40 Million |
+9.85% |
| 2008-12-31 | €165.39 Million ≈ $193.35 Million |
+0.49% |
| 2007-12-31 | €164.58 Million ≈ $192.41 Million |
+44.75% |
| 2006-12-31 | €113.70 Million ≈ $132.93 Million |
+58.27% |
| 2005-12-31 | €71.84 Million ≈ $83.99 Million |
-14.81% |
| 2004-12-31 | €84.33 Million ≈ $98.59 Million |
+3.95% |
| 2003-12-31 | €81.12 Million ≈ $94.84 Million |
+18.05% |
| 2002-12-31 | €68.72 Million ≈ $80.34 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to H&R GmbH & Co. KGaA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1518.7% over the analyzed period, indicating profitable operations and earnings retention.
H&R GmbH & Co. KGaA Net Assets Breakdown (December 2024)
H&R GmbH & Co. KGaA net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €283.77 Million | 66.48% |
| Common Stock | €95.16 Million | 22.29% |
| Other Comprehensive Income | €-11.63 Million | -2.72% |
| Other Components | €59.56 Million | 13.95% |
| Total Equity | €426.86 Million | 100.00% |
H&R GmbH & Co. KGaA Competitors by Market Cap
The table below lists competitors of H&R GmbH & Co. KGaA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CoreCard Corp
NYSE:CCRD
|
$183.90 Million |
|
Eco Atlantic Oil & Gas Ltd
V:EOG
|
$183.96 Million |
|
Sinphar Pharmaceutical Co Ltd
TW:1734
|
$183.96 Million |
|
Netfonds AG
XETRA:NF4
|
$184.07 Million |
|
Scicom MSC Bhd
KLSE:0099
|
$183.84 Million |
|
Consumer Portfolio Services Inc
NASDAQ:CPSS
|
$183.79 Million |
|
Ramky Infrastructure Limited
NSE:RAMKY
|
$183.76 Million |
|
Kao Hsiung Chang Iron & Steel Corp
TW:2008
|
$183.69 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in H&R GmbH & Co. KGaA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 413,017,000 to 426,861,000, a change of 13,844,000 (3.4%).
- Net income of 10,623,000 contributed positively to equity growth.
- Dividend payments of 3,722,000 reduced retained earnings.
- Other comprehensive income increased equity by 6,943,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €10.62 Million | +2.49% |
| Dividends Paid | €3.72 Million | -0.87% |
| Other Comprehensive Income | €6.94 Million | +1.63% |
| Total Change | €- | 3.35% |
Book Value vs Market Value Analysis
This analysis compares H&R GmbH & Co. KGaA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.58x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 2.61x to 0.58x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | €2.53 | €6.62 | x |
| 2003-12-31 | €2.87 | €6.62 | x |
| 2004-12-31 | €2.83 | €6.62 | x |
| 2005-12-31 | €2.65 | €6.62 | x |
| 2006-12-31 | €4.21 | €6.62 | x |
| 2007-12-31 | €5.35 | €6.62 | x |
| 2008-12-31 | €5.37 | €6.62 | x |
| 2009-12-31 | €5.93 | €6.62 | x |
| 2010-12-31 | €7.41 | €6.62 | x |
| 2011-12-31 | €7.89 | €6.62 | x |
| 2012-12-31 | €7.28 | €6.62 | x |
| 2013-12-31 | €6.19 | €6.62 | x |
| 2014-12-31 | €6.50 | €6.62 | x |
| 2015-12-31 | €6.70 | €6.62 | x |
| 2016-12-31 | €7.55 | €6.62 | x |
| 2017-12-31 | €8.37 | €6.62 | x |
| 2018-12-31 | €8.68 | €6.62 | x |
| 2019-12-31 | €8.72 | €6.62 | x |
| 2020-12-31 | €8.26 | €6.62 | x |
| 2021-12-31 | €9.74 | €6.62 | x |
| 2022-12-31 | €11.38 | €6.62 | x |
| 2023-12-31 | €11.10 | €6.62 | x |
| 2024-12-31 | €11.47 | €6.62 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently H&R GmbH & Co. KGaA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.49%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.79%
- • Asset Turnover: 1.32x
- • Equity Multiplier: 2.38x
- Recent ROE (2.49%) is below the historical average (9.39%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 6.43% | 2.31% | 1.43x | 1.95x | €-2.45 Million |
| 2003 | 7.44% | 2.76% | 1.26x | 2.13x | €-1.99 Million |
| 2004 | 9.80% | 1.51% | 1.51x | 4.30x | €-154.10K |
| 2006 | 38.06% | 5.30% | 1.99x | 3.61x | €31.90 Million |
| 2007 | 31.79% | 6.52% | 2.00x | 2.43x | €35.65 Million |
| 2008 | 7.17% | 1.14% | 2.39x | 2.63x | €-4.65 Million |
| 2009 | 13.82% | 3.29% | 1.65x | 2.55x | €6.93 Million |
| 2010 | 22.97% | 4.92% | 1.99x | 2.35x | €29.38 Million |
| 2011 | 15.95% | 3.18% | 1.90x | 2.63x | €14.36 Million |
| 2012 | 0.21% | 0.04% | 1.98x | 2.79x | €-21.79 Million |
| 2013 | -7.41% | -1.16% | 2.04x | 3.14x | €-32.95 Million |
| 2014 | -7.37% | -1.45% | 1.50x | 3.38x | €-36.31 Million |
| 2015 | 10.99% | 2.74% | 1.56x | 2.57x | €2.42 Million |
| 2016 | 13.91% | 4.07% | 1.45x | 2.35x | €10.79 Million |
| 2017 | 10.51% | 3.13% | 1.55x | 2.17x | €1.56 Million |
| 2018 | 6.75% | 1.94% | 1.53x | 2.28x | €-10.41 Million |
| 2019 | -0.42% | -0.13% | 1.28x | 2.59x | €-33.81 Million |
| 2020 | -2.93% | -1.03% | 1.17x | 2.42x | €-39.78 Million |
| 2021 | 13.84% | 4.22% | 1.36x | 2.41x | €13.92 Million |
| 2022 | 10.08% | 2.71% | 1.64x | 2.27x | €345.90K |
| 2023 | 2.56% | 0.78% | 1.50x | 2.19x | €-30.75 Million |
| 2024 | 2.49% | 0.79% | 1.32x | 2.38x | €-32.06 Million |
Industry Comparison
This section compares H&R GmbH & Co. KGaA's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $904,240,852
- Average return on equity (ROE) among peers: -48.25%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| H&R GmbH & Co. KGaA (2HRA) | €452.10 Million | 6.43% | 1.18x | $183.88 Million |
| LIFELINE SPAC I OYJ A EO1 (0CD) | $3.93 Million | 0.00% | 25.02x | $182.15 Million |
| GRAPHENE MANUFACT.GROUP (0GF) | $10.10 Million | -116.54% | 0.65x | $183.17 Million |
| Orion Engineered Carbons SA (0OE) | $478.50 Million | 21.63% | 2.83x | $299.30 Million |
| COVESTRO AG SP.ADR 1/2 (1CO1) | $7.02 Billion | -9.18% | 0.92x | $11.11 Billion |
| LOOP INDUSTRIES DL-001 (3L9) | $45.99 Million | -97.66% | 0.29x | $15.05 Million |
| Dotz Nano Ltd (57N) | $3.79 Million | -160.22% | 0.25x | $4.51 Million |
| TIDEWATER RENEWABLES LTD (7GZ) | $513.13 Million | -7.99% | 1.12x | $409.20 Million |
| DIRECTA PLUS PLC LS-0025 (88K) | $10.83 Million | -44.54% | 0.53x | $2.35 Million |
| TEKNA HOLDING ASA NK 2 (8VB) | $55.90 Million | -19.76% | 0.30x | $67.10 Million |
About H&R GmbH & Co. KGaA
H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts in Europe, Africa, Asia, and internationally. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other… Read more